IBCC Episode 99 - Hypertriglyceridemic Pancreatitis

Hypertriglyceridemic pancreatitis management relies heavily on supportive care rather than invasive interventions like plasmapheresis, which lack robust evidentiary support. Pathogenic damage likely stems from elevated free fatty acids rather than triglyceride levels alone, making insulin therapy a logical, safe adjunct to promote an anabolic state and inhibit fatty acid release. Clinicians should prioritize a conservative fluid resuscitation strategy to mitigate the risk of abdominal compartment syndrome and renal failure. While insulin infusions are standard, they should be titrated carefully alongside a low-fat diet to ensure efficacy. Heparin usage remains discouraged due to potential harm and limited clinical utility. Ultimately, ruling out alternative causes of pancreatitis and avoiding over-resuscitation are critical for improving patient outcomes, as many cases resolve effectively with basic metabolic stabilization and dietary restriction.